Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR Immunocore Holdings PLC (6YG.BE) Follow Add holdings 26.40 -0.60 (-2.22%) As of 8:23:35 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 6YG.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 6YG.BE View More All News Press Releases SEC Filings Immunocore to present at upcoming investor conferences Immunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in March Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts Immunocore Holdings Full Year 2024 Earnings: Misses Expectations Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... Q4 2024 Immunocore Holdings PLC Earnings Call Immunocore reports fourth quarter and full year 2024 financial results and provides a business update Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025 Related Tickers 9995.HK RemeGen Co., Ltd. 37.100 -10.39% BPMC Blueprint Medicines Corporation 88.51 +0.97% AUPH Aurinia Pharmaceuticals Inc. 8.00 -2.20% KROS Keros Therapeutics, Inc. 14.26 +0.35% NVAX Novavax, Inc. 6.71 +0.52%